The Journal of Urology · 1993 · 148 citations · 23 references
MedicineOncologyPharmacologyCancer PharmacologyCell SignalingSignal TransductionHormonal Cancer TherapyPeptide Hormone BiochemistryNeuroendocrine PeptidesPeptide Hormone PharmacologySomatostatin AnaloguesVasoactive Intestinal Peptide Signaling
The effects of bombesin, vasoactive intestinal polypeptide (VIP), and a somatostatin analog (RC-160) on the in vitro invasion of reconstituted basement membrane (Matrigel) by two human prostatic carcinoma cell lines were examined. Aggressively growing PC-3 cells were found to be invasive in this assay in contrast to the relatively indolent LNCaP cells. Bombesin increased penetration of basement membrane by both cell lines. Although VIP had no effect on invasion by PC-3 cells, it enhanced invasion by LNCaP cells in a dose-dependent manner. In agreement with these results, VIP stimulated adenylate cyclase activity only in LNCaP cells. In contrast to bombesin and VIP, RC-160 did not alter invasion by either cell line. Our results suggest that certain neuroendocrine peptides can increase the invasive potential of prostatic carcinoma cells and may thereby contribute to the rapid progression and aggressive clinical course of prostate tumors containing neuroendocrine elements.
23
A rapid in vitro assay for quantitating the invasive potential of tumor cells.
Adriana Albini, Yukihide Iwamoto, Kleinman Hk et al. · PubMed · 1987 · 1.8K citations
Medicine, Cell Biology, Oncology +16
Small cell carcinoma of the prostate part I a clinicopathologic study of 20 cases
Bernard Têtu, Jae Y. Ro, Alberto G. Ayala et al. · Cancer · 1987 · 273 citations
Bombesin stimulates growth of human prostatic cancer cellsin vitro
Mauro Bologna, Claudio Festuccia, Paola Muzi et al. · Cancer · 1990 · 217 citations · Full text
Medicine, Cancer Biology, Oncology +11
The course of neuroendocrine differentiation in prostatic carcinomas
Per‐Anders Abrahamsson, Sture Falkmer, K Fält et al. · Pathology - Research and Practice · 1989 · 192 citations
Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma
Dov Kadmon, Timothy C. Thompson, Garrett R. Lynch et al. · The Journal of Urology · 1991 · 175 citations